NEW YORK (GenomeWeb) – Finnish bioinformatics firm Euformatics announced today that it has received CE Marking for omnomicsNGS, a tool that helps labs interpret genetic variants and make clinical decisions.

The tool can help determine whether individual variants can have an effect on a patient's disease risk, or response to drugs or treatment, the company said. It performs variant annotation using the most recent disease-specific translational research and user-provided knowledge.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.